Global Glycated Hemoglobin Testing Market 2018-2022

  • ID: 4541151
  • Report
  • Region: Global
  • 119 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • MORE
About Glycated Hemoglobin Testing

Glycated Hemoglobin Testing helps to determine the average blood glucose level of individuals two to three months prior to the test to understand whether diabetes is controlled.

The analysts forecast the Global Glycated Hemoglobin Testing Market to grow at a CAGR of 9.13% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global glycated hemoglobin testing market. To calculate the market size, the report considers the revenue generated from the sales of instruments and glycated haemoglobin assays from hospitals, clinics, and other healthcare centers.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, global glycated hemoglobin testing market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche.
Market drivers
  • Growing elderly population
  • For a full, detailed list, view the full report
Market challenges
  • Limitations of HbA1c tests
  • For a full, detailed list, view the full report
Market trends
  • Rising demand for rapid diagnostic tests and POCT
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user
  • Comparison by end-user
  • Global glycated hemoglobin testing market by hospitals and clinics
  • Global glycated hemoglobin testing market by diagnostic laboratories
  • Global glycated hemoglobin testing market by academic and research institutes
  • Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas
  • EMEA
  • APAC – Market size and forecast 2017-2022
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Increased adoption of automation in diabetes care
  • Rising demand for rapid diagnostic tests and POCT
  • Increasing demand from developing countries
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
PART 15: APPENDIX
  • List of abbreviations
List of Exhbits
Exhibit 01: Global blood testing market
Exhibit 02: Global blood testing market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global glycated hemoglobin testing market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global glycated hemoglobin testing market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017 and 2022
Exhibit 18: Customer landscape
Exhibit 19: End-user – Market share 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Hospitals and clinics – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Hospitals and clinics – Year-over-year growth 2018-2022 (%)
Exhibit 23: Diagnostic laboratories – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Diagnostic laboratories – Year-over-year growth 2018-2022 (%)
Exhibit 25: R&D funding in diabetes 2013-2016 ($ millions)
Exhibit 26: Academic and research institutes – Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Academic and research institutes – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by end-user
Exhibit 29: Global glycated hemoglobin testing market – Market share by geography 2017-2022 (%)
Exhibit 30: Regional comparison
Exhibit 31: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in Americas
Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in EMEA
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 39: Top 3 countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Rise in population aged 65 years and above (% of total)
Exhibit 42: R&D funding in diabetes 2015-2016 ($ millions)
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Abbott overview
Exhibit 49: Abbott– Business segments
Exhibit 50: Abbott – Organizational developments
Exhibit 51: Abbott – Geographic focus
Exhibit 52: Abbott – Segment focus
Exhibit 53: Abbott – Key offerings
Exhibit 54: Bio-Rad Laboratories overview
Exhibit 55: Bio-Rad Laboratories– Business segments
Exhibit 56: Bio-Rad Laboratories– Organizational developments
Exhibit 57: Bio-Rad Laboratories – Geographic focus
Exhibit 58: Bio-Rad Laboratories – Segment focus
Exhibit 59: Bio-Rad Laboratories– Key offerings
Exhibit 60: Danaher overview
Exhibit 61: Danaher– Business segments
Exhibit 62: Danaher– Organizational developments
Exhibit 63: Danaher– Geographic focus
Exhibit 64: Danaher– Segment focus
Exhibit 65: Danaher– Key offerings
Exhibit 66: EKF Diagnostics overview
Exhibit 67: EKF Diagnostics – Business segments
Exhibit 68: EKF Diagnostics – Organizational developments
Exhibit 69: EKF Diagnostics – Geographic focus
Exhibit 70: EKF Diagnostics – Segment focus
Exhibit 71: EKF Diagnostics – Key offerings
Exhibit 72: F. Hoffmann-La Roche overview
Exhibit 73: F. Hoffmann-La Roche – Business segments
Exhibit 74: F. Hoffmann-La Roche – Organizational developments
Exhibit 75: F. Hoffmann-La Roche – Geographic focus
Exhibit 76: F. Hoffmann-La Roche – Segment focus
Exhibit 77: F. Hoffmann-La Roche – Key offerings
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • MORE
New Report Released: – Global Glycated Hemoglobin Testing Market 2018-2022

The author of the report recognizes the following companies as the key players in the global glycated hemoglobin testing market: Abbott, Bio-Rad Laboratories, Danaher, EKF Diagnostics, and F. Hoffmann-La Roche.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the increased adoption of automation in diabetes care”. Fully automated solutions can save costs of staffing and generate precise results.

According to the report, one driver influencing this market is the rising incidence of diabetes and related conditions. The growing prevalence of diabetes cater to the rise in the demand for diagnostic methods to detect diabetes.

Further, the report states that one challenge affecting this market is the high cost of tests and reimbursement restrictions. Manufacturers may not be able to fully recover their expenses since most health insurance companies have limitations on reimbursements.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll